Salud financiera de hoja de balance de Gufic Biosciences
Salud financiera controles de criterios 5/6
Gufic Biosciences tiene un patrimonio de accionistas total de ₹5.7B y una deuda total de ₹2.8B, lo que sitúa su ratio deuda-patrimonio en 49.4%. Sus activos y pasivos totales son ₹11.0B y ₹5.3B respectivamente. El BAIT de Gufic Biosciences es de ₹1.3B, por lo que su ratio de cobertura de intereses es de 9. Tiene efectivo e inversiones a corto plazo que ascienden a ₹194.0M.
Información clave
49.4%
Ratio deuda-patrimonio
₹2.84b
Deuda
| Ratio de cobertura de intereses | 9x |
| Efectivo | ₹193.96m |
| Patrimonio | ₹5.74b |
| Total pasivo | ₹5.30b |
| Activos totales | ₹11.05b |
Actualizaciones recientes sobre salud financiera
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17
These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13Recent updates
There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump
Nov 07We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings
Jun 06Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?
May 07Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 07This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid
Sep 15Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?
Aug 12Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest
Jun 11If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late
Mar 19What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?
Mar 01Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?
Jan 23
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company
Jan 05Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 18Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like
Dec 01Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?
Oct 19Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?
Sep 14I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut
Aug 24Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects
Aug 03Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)
Jul 09Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹5.8B) de GUFICBIO superan a sus pasivos a corto plazo (₹3.5B).
Pasivo a largo plazo: Los activos a corto plazo de GUFICBIO (₹5.8B) superan a sus pasivos a largo plazo (₹1.8B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de GUFICBIO (46%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de GUFICBIO ha pasado de 123.8% a 49.4% en los últimos 5 años.
Cobertura de la deuda: La deuda de GUFICBIO está bien cubierta por el flujo de caja operativo (24.6%).
Cobertura de intereses: Los pagos de intereses de la deuda de GUFICBIO están bien cubiertos por el BAIT (9x cobertura).